The Michigan Institute of Women’s Health is currently conducting a clinical trial on the MonaLisa Touch treatment. A randomized, double-blind placebo controlled study of 34 participants aims to study the effectiveness of MonaLisa Touch on genitourinary syndrome of menopause. Essentially, researchers at this institute want to know if both vaginal and urinary symptoms of menopause (such as vaginal dryness and urinary frequency) caused by menopause will be helped by the MonaLisa Touch treatments.
How will the clinical trial work? Participants will be in menopause and are not allowed to use estrogen or any hormone-affecting products that could interfere. Both groups of women will experience the same treatment– each will have the CO2 laser inserted in identical fashion, but some of the women will have the laser in “stand-by” mode, and the others will have the laser actually turned on. This way, researchers will not be able to know which women received the actual treatment and which did not.
How are the symptoms are being studied? Within a one-year time frame, participants will score the following symptoms on a scale of 0-3 (none 0, mild 1, moderate 2 and severe 3): painful intercourse, vaginal dryness, irritative bladder symptoms, and vaginal burning.
My thoughts: I think it’s pretty obvious what’s going to happen. Ladies in menopause who receive the “stand-by” treatment with the laser not actually turned on will continue to experience vaginal dryness, painful intercourse, bladder irritation, and all the genitourinary symptoms that come with menopause. Ladies who are in the group that receive the actual treatment with the laser turned on are going to have significant improvements. It will be painstakingly obvious that MonaLisa Touch drastically reduces or eliminates vaginal atrophy symptoms due to menopause.
Perhaps with more studies like this, one day MonaLisa Touch might be covered by insurance companies!